HCA Holdings Inc. Stock
HCA Holdings Inc. Stock
There is an upward development for HCA Holdings Inc. compared to yesterday, with an increase of €6.50 (2.200%).
With 22 Buy predictions and not a single Sell prediction HCA Holdings Inc. is an absolute favorite of our community.
On the other hand, the target price of 303 € is below the current price of 303.2 € for HCA Holdings Inc., so the potential is actually -0.07%.
Pros and Cons of HCA Holdings Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of HCA Holdings Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
HCA Holdings Inc. | 2.200% | 6.051% | 0.066% | 19.511% | 23.957% | 73.704% | 169.272% |
Anthem Inc. | 0.280% | 2.227% | 5.905% | 19.143% | 18.019% | 51.087% | 110.429% |
Quest Diagnostics Inc. | -0.590% | 1.101% | 4.898% | 7.173% | 3.296% | 10.253% | 46.023% |
Laboratory Corp. Of America (labcorp) | 1.060% | 0.000% | -2.591% | -7.843% | -8.738% | -17.796% | 30.320% |
Comments
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at TD Cowen from $371.00 to $360.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Barclays PLC from $356.00 to $367.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HCA provided by MarketBeat
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Royal Bank of Canada from $322.00 to $329.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for HCA provided by MarketBeat